Showing results (1471-1480 of 3,791) with videos related to

Sort By:
Pageof 380
Oncoimmunology|June 14, 2024
Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34Elisabetta Bartolini, Kris Van Moer, Bassam Janji
Oncoimmunology|May 30, 2024
Immunogenic oncolysis by tigilanol tiglateJonathan G Pol, Manuela Lizarralde-Guerrero, Guido Kroemer
Oncoimmunology|May 30, 2024
CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survivalSiyue Nie, Yujie Song, Kun Hu, et al.
Oncoimmunology|July 8, 2024
Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in SwedenOsama Hamida, Frans Karlsson, Andreas Lundqvist, et al.
Oncoimmunology|July 9, 2024
Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodesKazumi Okamura, Lifang Wang, Satoshi Nagayama, et al.
Oncoimmunology|May 15, 2024
CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophageRongyuan Wei, Junquan Song, Hongda Pan, et al.
Oncoimmunology|August 18, 2023
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCsAlisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, et al.
Oncoimmunology|October 9, 2023
Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cellsConstanza Rodriguez, Cintia L Araujo Furlan, Jimena Tosello Boari, et al.
Oncoimmunology|October 27, 2023
CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockadeSabrina N Bossio, Carolina Abrate, Jimena Tosello Boari, et al.
Oncoimmunology|October 2, 2023
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protectionTrevor S Anderson, Amanda L McCormick, Elizabeth A Daugherity, et al.
Pageof 380